A new add-on therapy administered every six months targets key inflammatory pathways in asthma and chronic rhinosinusitis ...

A new option for hard-to-control asthma: The FDA has approved Exdensur (depemokimab-ulaa) as an add-on maintenance treatment for people with severe asthma. Designed to reduce flare-ups: The injectable ...

LOS ANGELES - Researchers say they've found a possible new treatment for adults with hard-to-control asthma. Their discovery, however, came at a price. Scientists of a U.S. government-funded asthma ...

Glenview, Illinois –The American College of Chest Physicians® (CHEST) recently released a new clinical guideline on biologic management in severe ...

Cold weather and air pollution can worsen bronchial asthma. Here’s why winter triggers flare-ups and how patients can reduce ...

What Is Exdensur, and Why Does It Matter? Exdensur (depemokimab) is a new type of ultra long-acting biologic medicine approved by the FDA as an add-on maintenance treatment for severe eosinophilic ...

According to NICE, the technologies suggested for use allow people with asthma to use apps or online tools to access ...

More must be done to ensure that asthma patients get access to cutting-edge treatments, experts have said, after research ...

New draft guidance recommends using eight apps on the health service for the next three years while further evidence is ...

Sandoz Group Ltd (SDZXF) announced an update on their ongoing clinical study. Study Overview: Sandoz Group Ltd is conducting a clinical study titled A Randomized, Multicenter, Multiple-dose, ...

New York’s health department said the week ending Dec. 20 marked the most flu cases the state had recorded in a single week since 2004 - 71,000.

As flu cases rise across the U.S., those who end up contracting the virus have treatments available that may help reduce ...